Chronic treatment with irinotecan activates the PI3K/Akt/mTOR pathway in HT-29 colon cancer xenografts

被引：0
|
作者：
Souza, K. K. [1 ]
Oliveira, J. C. [1 ]
Dias, M. M. [1 ]
Ropelle, E. R. [1 ]
Rocha, G. Z. [1 ]
Costa, F. O. [1 ]
Carvalheira, J. B. C. [1 ]
机构：
[1] Univ Estadual Campinas, Campinas, SP, Brazil
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71298-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [41] Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
    Yu, Le
    Wei, Jessica
    Liu, Pengda
    SEMINARS IN CANCER BIOLOGY, 2022, 85 : 69 - 94
  • [42] Digoxigenin activates autophagy in hepatocellular carcinoma cells by regulating the PI3K/AKT/mTOR pathway
    Mengqing Ma
    Rui Hu
    Qi Huang
    Jing Li
    Minling Lv
    Jialing Sun
    Xin Zhong
    Jinyu Yi
    Lanfen Peng
    Wenxing Feng
    Wenfeng Ma
    Zhiyi Han
    Wei Zhang
    Xinfeng Sun
    Bolin Zhan
    Xingning Liu
    Xiaozhou Zhou
    Cancer Cell International, 24 (1)
  • [43] Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts
    Liu, CN
    Willingham, M
    Liu, JQ
    Gmeiner, WH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (02) : 303 - 308
  • [44] The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
    Paplomata, Elisavet
    O'Regan, Ruth
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (04) : 154 - 166
  • [45] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    S-U Woo
    T Sangai
    A Akcakanat
    H Chen
    C Wei
    F Meric-Bernstam
    Oncogenesis, 2017, 6 : e385 - e385
  • [46] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
    Li, HaiXia
    Zeng, JianFang
    Shen, Keng
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
  • [47] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    Woo, S-U
    Sangai, T.
    Akcakanat, A.
    Chen, H.
    Wei, C.
    Meric-Bernstam, F.
    ONCOGENESIS, 2017, 6 : e385 - e385
  • [48] Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
    Roudsari, Nazanin Momeni
    Lashgari, Naser-Aldin
    Momtaz, Saeideh
    Abaft, Shaghayegh
    Jamali, Fatemeh
    Safaiepour, Pardis
    Narimisa, Kiyana
    Jackson, Gloria
    Bishayee, Anusha
    Rezaei, Nima
    Abdolghaffari, Amir Hossein
    Bishayee, Anupam
    PHARMACEUTICS, 2021, 13 (08)
  • [49] Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway
    Ching, Christina Barbara
    Hansel, Donna Elizabeth
    LABORATORY INVESTIGATION, 2010, 90 (10) : 1406 - 1414
  • [50] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    Antonino Glaviano
    Aaron S. C. Foo
    Hiu Y. Lam
    Kenneth C. H. Yap
    William Jacot
    Robert H. Jones
    Huiyan Eng
    Madhumathy G. Nair
    Pooyan Makvandi
    Birgit Geoerger
    Matthew H. Kulke
    Richard D. Baird
    Jyothi S. Prabhu
    Daniela Carbone
    Camilla Pecoraro
    Daniel B. L. Teh
    Gautam Sethi
    Vincenzo Cavalieri
    Kevin H. Lin
    Nathalie R. Javidi-Sharifi
    Eneda Toska
    Matthew S. Davids
    Jennifer R. Brown
    Patrizia Diana
    Justin Stebbing
    David A. Fruman
    Alan P. Kumar
    Molecular Cancer, 22
12345